Upstream Bio Inc. (UPB)

$27.02

+0.45

(+1.69%)

Market is closed - opens 8 PM, 08 Nov 2024

Performance

  • $26.09
    $27.36
    $27.02
    downward going graph

    3.44%

    Downside

    Day's Volatility :4.64%

    Upside

    1.24%

    downward going graph
  • $20.74
    $29.46
    $27.02
    downward going graph

    23.24%

    Downside

    52 Weeks Volatility :29.6%

    Upside

    8.28%

    downward going graph

Returns

PeriodUpstream Bio Inc.Index (Russel 2000)
3 Months
22.82%
0.0%
6 Months
22.82%
0.0%
1 Year
22.82%
0.0%
3 Years
22.82%
-27.6%

Highlights

Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
0.0%
Return On Equity TTM
0.0%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
0.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Upstream Bio Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Upstream Bio Inc.
Upstream Bio Inc.
22.82%
22.82%
22.82%
22.82%
22.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-17.98%
-13.74%
0.21%
32.39%
141.22%
Biontech Se
Biontech Se
-10.32%
19.69%
8.29%
-55.53%
471.7%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
0.38%
78.75%
60.7%
44.82%
192.62%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
9.48%
19.97%
33.29%
161.38%
149.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Upstream Bio Inc.
Upstream Bio Inc.
NA
NA
NA
0.0
0.0
0.0
NA
NA
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
20.53
20.53
1.2
44.89
0.17
0.07
NA
272.04
Biontech Se
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-1.87
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.27
0.19
-0.03
0.13
NA
60.66
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Upstream Bio Inc.
Upstream Bio Inc.
NA
NA
22.82%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$91.1B
141.22%
20.53
33.61%
Biontech Se
Biontech Se
Buy
$25.6B
471.7%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$35.2B
192.62%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.9B
149.59%
32.84
-4.51%

Company Information

Organization
Upstream Bio Inc.
Industry
Miscellaneous

FAQs